clinical trial · NCT04819776
Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
Bipolar I DisorderIloperidoneIloperidone Placebo
brief summary
The aim of this study is to investigate the efficacy, safety, and tolerability of iloperidone compared with placebo in treating acute manic or mixed episodes associated with Bipolar I Disorder.
started
Mar 22, 2021
primary completion
Sep 7, 2022
completion
Aug 16, 2023
last updated
Apr 18, 2024
official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iloperidone for 4 Weeks in the Treatment of Patients With Acute Manic Episodes Associated With Bipolar I Disorder
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol